Aeroflow Health acquires maternal mental health platform Canopie, HPV vaccination dramatically reduces cervical cancer deaths, and Intu Diagnostics raises €1.1 million for lab-free testing.
Xella Health launched an AI precision health platform built for the XX chromosome, assessing the probability of over 130 conditions specific to female biology, aiming to accelerate diagnoses for conditions like endometriosis. The continued integration of specialized health services is evident as Aeroflow Health's acquisition of Canopie creates a combined maternal health platform spanning supplies, clinical services, and mental wellness. Concurrently, new research reveals England's HPV vaccination program, initiated nearly two decades ago, significantly reduced cervical cancer mortality among young women. Five takes inside, plus a quick-hits roundup.
VIA FemTech World
Xella Health has raised US$4.7m in angel and pre-seed funding. The company launched the first AI precision health platform built for the XX chromosome, which assesses the probability of over 130 conditions specific to female biology. Xella aims to address diagnostic imprecision and limited clinical research in female biology. This development could accelerate accurate diagnoses for conditions like endometriosis, which currently sees seven-to-ten-year delays for women.
Read the full story →
— The Luteal Editorial Team
VIA FemTech Insider
Aeroflow Health, a technology-enabled healthcare company serving 1.7 million expecting and new mothers annually, acquired digital health company Canopie. This acquisition creates a combined maternal health platform providing lactation supplies, feeding support, perinatal education, mental health, and physical wellness programs. For femtech operators, this consolidation indicates a strategic move towards integrated maternal health solutions.
Read the full story →
— The Luteal Editorial Team
VIA EU-Startups
Intu Diagnostics closed a €1.1 million strategic bridge round, bringing its total funding to over €3 million. BSV Ventures, SAB (Saxonian Development Bank), and business angels supported the round. The 2023 spin-off of Fraunhofer Society focuses its first application on HPV testing in women's health.
Read the full story →
— The Luteal Editorial Team
VIA Nature Medicine
A new study reveals England's HPV vaccination program, initiated almost two decades ago, significantly reduced cervical cancer mortality among young women. This data reinforces the long-term public health impact of HPV vaccination for women's health operators and investors.
Read the full story →
— The Luteal Editorial Team
VIA Contemporary OB/GYN
Only one third of nocturnal wakefulness during the menopausal transition directly links to hot flashes. VMS-targeted therapies are insufficient for many women with sleep disruption during this period. Sleep society guidelines support cognitive behavioral therapy for insomnia (CBT-I), which is accessible through free digital platforms. Femtech operators can integrate CBT-I solutions for comprehensive menopause care.
Read the full story →
— The Luteal Editorial Team
